PGXL Labs, Essential Molecular Testing Ink National Distribution Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Pharmacogenetic testing firm PGXL Laboratories announced on Thursday a long-term national distribution deal with Essential Molecular Testing for PGXL's drug sensitivity testing.

The partnership, called PGXL Partners, provides the Louisville, Ky.-based laboratory a larger sales force to address growing demand for its tests. In a statement, PGXL Labs President Roland Valdes Jr., said that the company has increased sales of its tests to thousands each month from hundreds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.